How Dangerous Is an Atherectomy? Risks and Safety

Atherectomy is generally a safe procedure, but it carries real risks that vary depending on the artery being treated, the type of device used, and the experience of the person performing it. In-hospital mortality after coronary atherectomy runs around 1%, and serious cardiac events within 30 days occur in roughly 1.5% of cases. Those numbers have been improving over time, but they are not zero, and specific complications like slow blood flow, vessel perforation, and downstream debris are part of the procedure’s profile. The picture also shifts meaningfully when you move from the heart’s arteries to the legs, where long-term outcomes remain a matter of active debate.

What Procedure-Day Complications Look Like

During and immediately after an atherectomy, the most commonly tracked risks are heart attack, stroke, emergency surgery, and death. A large study from Thailand examining over 600 rotational atherectomy procedures in heavily calcified coronary arteries found that about one in five procedures triggered some form of periprocedural complication. That sounds alarming, but most of those events were manageable issues like transient slow flow through the treated artery. The rate of major adverse cardiac and cerebrovascular events at 30 days was 1.5%, and in-hospital mortality was about 1.1%.¹

National-level data from the United States tells a broadly consistent and somewhat encouraging story. An analysis of over 65,000 coronary atherectomy procedures from a large cardiovascular registry found that even as atherectomy use nearly tripled between 2009 and 2016, the rates of heart attack and major adverse cardiac events during hospitalization declined over the same period.² That trend likely reflects better technique, improved device technology, and more judicious patient selection as operators gained experience.

Coronary Versus Peripheral Atherectomy

The risk profile changes substantially depending on whether the target is a coronary artery or a leg artery. Coronary atherectomy is typically done to shave down calcium deposits so a stent can be placed properly. In the legs, atherectomy is more often used to remove plaque from the femoral and popliteal arteries that supply blood below the knee. The stakes are different: in the heart, you worry about heart attack and death; in the legs, the primary concern is whether the limb can be saved.

One analysis of long-term outcomes in the legs found that atherectomy patients had a higher five-year rate of major adverse limb events compared to patients treated with balloon angioplasty or stenting alone. After adjusting for differences between patients, atherectomy was associated with a higher risk of amputation compared to stenting, with the risk of major amputation roughly tripled.³ That finding raised serious questions about whether atherectomy was being overused in peripheral arteries.

A more recent study looking at the same question, however, found no meaningful difference in the combined risk of death and amputation, or in major adverse limb events, between atherectomy and other endovascular approaches for leg arteries over a median follow-up of about two and a half years.⁴ The discrepancy between studies probably comes down to how sick the patients were to begin with. Atherectomy tends to be chosen for more complex cases, and not every analysis fully accounts for that selection bias. The honest read is that peripheral atherectomy is neither clearly more dangerous nor clearly safer than the alternatives for most patients, though the conversation is far from settled.

How Different Devices Compare

Not all atherectomy is the same. The four main device categories each have distinct mechanical approaches and somewhat different complication profiles.

Rotational atherectomy uses a diamond-tipped burr spinning at very high speeds to grind through calcified plaque. It is the workhorse for heavily calcified coronary lesions. Orbital atherectomy works on a similar principle but uses an eccentrically mounted crown that sands the calcium at a slightly lower speed. A meta-analysis comparing the two found no significant differences in overall major adverse cardiac events, heart attack rates, or death between devices.⁵ However, orbital atherectomy was associated with lower rates of in-hospital heart attack and lower one-year rates of needing a repeat procedure. The trade-off: orbital atherectomy showed a higher rate of coronary dissection and device-related perforation. A smaller study focused specifically on calcified left main artery disease found no statistical differences in major adverse events between the two devices in either the hospital stay or at one month.⁶

Directional atherectomy physically cuts and collects plaque rather than grinding it. In the legs, a prospective study of over 800 patients found periprocedural embolization in about 4% of cases, vessel perforation in about 5%, and abrupt vessel closure in 2%.⁷ A study of directional atherectomy for common femoral artery disease reported an overall procedural complication rate of about 10%, though nearly all complications were handled without surgery, and freedom from major adverse events at 30 days was over 99%.⁸

Excimer laser atherectomy uses ultraviolet light to vaporize plaque. It occupies a niche role, most often used for in-stent restenosis or lesions that other devices cannot handle. The evidence base is thinner, but the general consensus is that it is safe in experienced hands, with the caveat that procedural complications still need careful consideration.⁹

Slow Flow and Distal Embolization

Two complications come up again and again in atherectomy literature, and they are worth understanding individually because they are the procedure’s signature risks.

Slow flow (or no-reflow) happens when the blood downstream of the treated site slows dramatically or stops, usually because tiny particles of ground-up plaque lodge in the small vessels. In rotational atherectomy, this occurs in roughly a quarter of procedures, based on a randomized study that tested low versus high burr speeds and found the same 24% incidence in both groups.¹⁰ The risk of slow flow increases with longer lesions and larger burr sizes relative to the artery, because more debris is generated when you are grinding a longer stretch or taking a more aggressive pass.¹¹ Most slow-flow events resolve with medications given during the procedure, but severe cases can cause a heart attack.

Distal embolization is the related phenomenon in leg arteries: chunks of plaque break loose and travel downstream, potentially blocking smaller vessels in the foot or calf. A review of atherectomy evidence in peripheral arteries found that while atherectomy achieves high initial success rates and reduces the need for stent placement, it comes with an increased risk of this kind of downstream debris compared to balloon-only approaches.¹² A head-to-head comparison of atherectomy versus balloon angioplasty for leg arteries confirmed the pattern: atherectomy showed a 2% embolization rate versus about 1.1% for balloons alone.¹³ Embolic protection devices, essentially tiny filters placed downstream during the procedure, can catch loose debris. Their use during directional atherectomy in the legs has been shown to be both safe and effective at preventing distal embolization.

Atherectomy Compared to Balloon Angioplasty and Stenting

When patients ask whether atherectomy is more dangerous than the alternatives, the answer depends on which outcome you care about and which artery is involved.

For leg arteries, a meta-analysis comparing atherectomy plus balloon angioplasty to balloon angioplasty alone found no significant differences in death, amputation, technical success, perforation, or embolization between the groups. The one notable finding was that adding atherectomy significantly reduced the rate of vessel dissection compared to balloons alone.¹⁴ That dissection reduction is meaningful because dissections during balloon angioplasty often lead to emergency stent placement.

When comparing atherectomy to stenting in leg arteries, the picture is more nuanced. Atherectomy showed lower rates of dissection and perforation, plus shorter hospital stays. But it had lower technical success rates, higher embolization rates, and at one year, a higher rate of major amputation on the treated side.¹³ For smaller arteries below the knee, which supply blood to the foot in patients at risk of limb loss, a comparison of atherectomy versus balloon angioplasty found no difference in major adverse events during the procedure, and the 12-month major amputation rates were virtually identical, around 4.5% in both groups.¹⁵

The overall takeaway is that atherectomy does not dramatically increase or decrease short-term danger compared to balloons and stents. Its main procedural advantage is reducing dissection, and its main procedural disadvantage is embolization. The choice often comes down to the specific anatomy of the blockage rather than a blanket safety comparison.

Who Faces Higher Risk

Age is the most powerful predictor of complications after coronary atherectomy. A large analysis stratifying patients by age found a stepwise increase in nearly every adverse outcome. Compared to younger adults, patients in their late 60s and 70s had about 40% higher odds of death, kidney injury, and gastrointestinal bleeding. Patients in their 80s faced roughly double the odds of dying in the hospital and more than triple the odds of cardiac tamponade, a dangerous collection of fluid around the heart. Those over 85 had the steepest increase in every category measured.¹⁶

Sex matters too. Women undergoing rotational atherectomy had higher rates of coronary dissection, cardiac tamponade, and significant bleeding compared to men.¹⁷ Smaller coronary arteries in women likely contribute to this disparity, since the burr takes up more of the vessel’s diameter.

Chronic kidney disease adds another layer of risk. A trial specifically enrolling patients with severely calcified coronary arteries and chronic renal failure found that both planned (elective) and rescue (bailout) atherectomy strategies resulted in comparable rates of major cardiac events over a median follow-up of about four years, with cardiovascular death rates under 10% in both groups.¹⁸ That is reasonable for a group of patients with an average age in the late 70s and significant comorbidities, but it underscores that kidney patients should expect a harder road regardless of the strategy chosen.

Why Your Operator’s Caseload Matters

One of the most actionable findings in the atherectomy literature is that operator experience correlates with outcomes. An analysis of nearly 8,000 rotational atherectomy procedures from a national database found a clear inverse relationship between the number of procedures an operator performed per year and in-hospital mortality, major adverse events, arterial complications, emergency cardiac surgery, and major bleeding. Each additional case per year was associated with slightly better outcomes across the board.¹⁹

The concerning detail: over half of operators in that database performed fewer than four rotational atherectomy procedures per year, the threshold below which adverse events started climbing. This is not a niche finding. Earlier research on percutaneous coronary interventions more broadly found the same pattern, with complications more closely tied to the logarithm of an operator’s annual caseload than to their total years of experience.²⁰ In plain terms, a cardiologist who did 200 stent procedures last year but only two atherectomies may not be the safest choice. Current volume in atherectomy specifically, not general cardiac catheterization experience, is what the data says matters.

If you are being offered an atherectomy, it is entirely reasonable to ask your interventionalist how many they perform per year. A number in the teens or higher is reassuring. Low single digits should prompt a conversation about whether the procedure could be done at a higher-volume center.

Steps That Reduce Risk During the Procedure

Operators have several tools to make atherectomy safer. Using a smaller burr relative to the artery’s diameter reduces the risk of slow flow, and keeping passes short and intermittent prevents heat buildup and excessive debris. Flush solutions infused through the catheter during rotational atherectomy help keep the burr cool and the artery open. One cocktail combining two blood-vessel-relaxing drugs, nicardipine and adenosine, appears effective at minimizing no-reflow events and heart muscle injury during the procedure.²¹ A randomized trial comparing two different flush solutions found roughly comparable rates of slow flow, around 20 to 30%, but showed that the choice of flush affects coronary spasm rates, so the composition of the cocktail is not a trivial decision.²²

Off-label use of rotational atherectomy, meaning using a larger burr or more aggressive technique than the manufacturer recommends, significantly increases the rate of slow flow and periprocedural heart attack. One study found slow flow in 30% of off-label cases versus 18% on-label, and periprocedural heart attacks in about 9% versus 2%.²³ Severe complications like burr entrapment or vessel perforation were rare in both groups, which suggests the main safety lever operators can pull is sticking to conservative device sizing.

For peripheral atherectomy, embolic protection devices placed downstream have become an increasingly standard safeguard. In the legs, where embolization rates are higher than in the heart, catching debris before it reaches the foot can be the difference between a routine recovery and an emergency.

Long-Term Outcomes and Restenosis

Surviving the procedure is one thing; staying open is another. Restenosis, where the artery narrows again at the treated site, is the long-term Achilles’ heel of all plaque-removal strategies, including atherectomy. Early data from directional coronary atherectomy found restenosis rates of about 31% for newly treated coronary lesions, climbing to nearly 50% for lesions that had already been ballooned once before. In saphenous vein bypass grafts, the numbers were worse: over 50% for new lesions and above 80% for previously treated ones.²⁴ Restenosis typically showed up within about four to five months.

Modern practice has largely addressed coronary restenosis by pairing atherectomy with drug-eluting stents, which release medication locally to inhibit scar tissue growth. Atherectomy in this context is a preparation step rather than a standalone treatment. In the legs, a similar evolution is underway. A study comparing drug-coated balloons alone versus rotational atherectomy followed by drug-coated balloons for treating in-stent blockages in the upper leg arteries found that adding atherectomy produced dramatically better five-year results. Freedom from needing another procedure was about 64% in the atherectomy-plus-balloon group versus 31% in the balloon-only group, and five-year freedom from blood clots was roughly 75% versus 37%.²⁵

Where the Procedure Happens

An increasing number of peripheral atherectomy procedures are performed in office-based labs rather than hospitals. This shift has prompted legitimate questions about safety. A study of nearly 3,000 vascular procedures done in an office-based setting, selecting low-to-moderate-risk patients, reported zero in-lab mortality, zero heart attacks, zero strokes, zero major bleeds, and zero emergency hospital transfers within 72 hours. Minor complications occurred in half a percent of cases.²⁶ A larger analysis of the trend toward office-based labs found that physicians who transitioned to office settings saw a decrease in above-ankle amputation rates at both 30 days and one year, though the rates of limb-threatening events and death were comparable to hospital-based care.²⁷

The important caveat is patient selection. Office-based labs work well for straightforward peripheral procedures in patients who are not at high risk of cardiovascular collapse. Complex coronary atherectomy, emergency cases, and patients with severe heart failure or kidney disease still belong in a hospital where full surgical backup is available. If you are offered an office-based atherectomy, the safety data is reassuring for simpler peripheral cases, but ask whether you would be better served by a hospital setting if your anatomy or medical history is complicated.

Rare but Serious Delayed Complications

Most atherectomy complications occur during or immediately after the procedure, but delayed events do happen. One documented case involved a patient who developed a pseudoaneurysm, essentially a contained rupture of the artery wall, six days after rotational atherectomy in the popliteal artery behind the knee. The patient showed up to the emergency room with severe calf pain and swelling, and imaging revealed the artery had ruptured at the treatment site, with a significant drop in blood counts requiring intervention.²⁸ Events like this are rare enough to warrant case reports rather than showing up in large registry data, but they underscore why follow-up appointments and awareness of warning signs matter. Sudden pain, swelling, or bruising at or below the treatment site in the days after atherectomy should prompt an urgent call to your physician.